BG61066B1 - Авирулентна противобясна ваксина - Google Patents

Авирулентна противобясна ваксина Download PDF

Info

Publication number
BG61066B1
BG61066B1 BG97964A BG9796493A BG61066B1 BG 61066 B1 BG61066 B1 BG 61066B1 BG 97964 A BG97964 A BG 97964A BG 9796493 A BG9796493 A BG 9796493A BG 61066 B1 BG61066 B1 BG 61066B1
Authority
BG
Bulgaria
Prior art keywords
strain
mutant
avirulent
mutants
glycoprotein
Prior art date
Application number
BG97964A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG97964A (bg
Inventor
Jacqueline Benejean
Anne Flamand
Marie-Christine Tuffereau
Patrice Coulon
Florence Lafay
Original Assignee
Virbac Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Societe Anonyme filed Critical Virbac Societe Anonyme
Publication of BG97964A publication Critical patent/BG97964A/bg
Publication of BG61066B1 publication Critical patent/BG61066B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BG97964A 1992-07-20 1993-07-16 Авирулентна противобясна ваксина BG61066B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9208947A FR2693655B1 (fr) 1992-07-20 1992-07-20 Vaccin antirabique avirulent.

Publications (2)

Publication Number Publication Date
BG97964A BG97964A (bg) 1994-04-29
BG61066B1 true BG61066B1 (bg) 1996-10-31

Family

ID=9432070

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97964A BG61066B1 (bg) 1992-07-20 1993-07-16 Авирулентна противобясна ваксина

Country Status (20)

Country Link
US (1) US5853735A (de)
EP (1) EP0583998B1 (de)
AT (1) ATE175877T1 (de)
BG (1) BG61066B1 (de)
BR (1) BR9302910A (de)
CA (1) CA2100591C (de)
CZ (1) CZ283400B6 (de)
DE (1) DE69323130T2 (de)
FI (1) FI933210A7 (de)
FR (1) FR2693655B1 (de)
HR (1) HRP931065B1 (de)
HU (1) HU219266B (de)
MA (1) MA22938A1 (de)
MX (1) MX9304349A (de)
PL (1) PL172853B1 (de)
RO (1) RO112582B1 (de)
RU (1) RU2128519C1 (de)
SI (1) SI9300392A (de)
SK (1) SK280104B6 (de)
TN (1) TNSN93083A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915703B1 (pt) * 1998-11-27 2012-09-04 mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.
IL146732A0 (en) 1999-06-03 2002-07-25 Nippon Suisan Kaisha Ltd Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
US7074413B2 (en) 2000-03-23 2006-07-11 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
KR20040029377A (ko) * 2001-07-20 2004-04-06 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 공수병의 예방 접종 및 중추신경계 질환의 유전자 요법을위한 인산화 부위의 핵단백질 돌연변이를 갖는 약독화공수병 바이러스
ATE307606T1 (de) 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
DE60231821D1 (de) * 2001-10-10 2009-05-14 Univ Jefferson Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
EP1415665A3 (de) * 2002-11-01 2004-06-30 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. BHV5 Mutanten
RS51371B (sr) 2004-07-12 2011-02-28 Thomas Jefferson University, Office Of Technology Transfer Smeše rekombinantnog rabijes virusa
CN101287838B (zh) 2005-10-14 2016-03-30 美国政府健康及人类服务部，疾病控制和预防中心 狂犬病病毒组合物和方法
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
RU2694836C1 (ru) * 2018-12-14 2019-07-17 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения антигена вируса бешенства для серологической диагностики

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent

Also Published As

Publication number Publication date
MA22938A1 (fr) 1994-04-01
FR2693655A1 (fr) 1994-01-21
CZ283400B6 (cs) 1998-04-15
FR2693655B1 (fr) 1994-10-14
RU2128519C1 (ru) 1999-04-10
BG97964A (bg) 1994-04-29
CA2100591A1 (en) 1994-01-21
CZ140293A3 (en) 1994-02-16
HU9302091D0 (en) 1993-11-29
BR9302910A (pt) 1994-02-16
FI933210L (fi) 1994-01-21
TNSN93083A1 (fr) 1994-03-17
MX9304349A (es) 1994-06-30
US5853735A (en) 1998-12-29
PL299739A1 (en) 1994-01-24
PL172853B1 (pl) 1997-12-31
DE69323130D1 (de) 1999-03-04
DE69323130T2 (de) 1999-06-17
EP0583998B1 (de) 1999-01-20
HRP931065A2 (en) 1995-02-28
SK280104B6 (sk) 1999-08-06
HU219266B (en) 2001-03-28
FI933210A7 (fi) 1994-01-21
CA2100591C (en) 2003-02-18
HRP931065B1 (en) 1999-12-31
RO112582B1 (ro) 1997-11-28
EP0583998A1 (de) 1994-02-23
SI9300392A (en) 1994-06-30
HUT69961A (en) 1995-09-28
FI933210A0 (fi) 1993-07-14
SK76193A3 (en) 1994-06-08
ATE175877T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
US4810634A (en) Pseudorabies virus mutants incapable of producing glycoprotein X
Bourhy et al. Antigenic and molecular characterization of bat rabies virus in Europe
Ludwig et al. Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenic potential
Morimoto et al. Genetic engineering of live rabies vaccines
DE69637264T2 (de) Virales Material und Multiple-Sklerose assoziierte Nukleotidfragmente mit diagnostischen, prophylaktischen und therapeutischen Verwendungen
Schumacher et al. SAG-2 oral rabies vaccine
RU2128519C1 (ru) Авирулентная вакцина против бешенства, штамм вируса бешенства, используемый для изготовления вакцины против бешенства и способ его получения
US6241989B1 (en) Recombinant multivalent viral vaccine
Flamand et al. Avirulent mutants of rabies virus and their use as live vaccine
Yang et al. Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs
US5632989A (en) Attenuated, live vaccine for Delaware strain IBDV
Yokoyama et al. Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene
DK170393B1 (da) Avirulent rabies-vaccine samt avirulent mutant af stammen SAD Berne
US7087234B1 (en) Recombinant multivalent viral vaccine
CA2382993A1 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
US5275934A (en) Method of detecting viral infection in vaccinated animals
US5128128A (en) Virus vaccine
EP0263207B1 (de) Virus-Vakzin
Puentes et al. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources
JPH05503209A (ja) イヌパルボウイルス（ｃｐｖ）を含む弱毒イヌパルボウイルスワクチンとイヌ科動物におけるｃｐｖ感染予防
IL149173A (en) Attenuated recombinant mutants of the rabies virus and vaccines prepared from them